LeMaitre Vascular logo
LeMaitre Vascular
LMAT | NASDAQ
Chart Builder DCF Calculator
$77.01
-$1.28 (-1.63%)
At close: Nov 16, 2026, 4:00 PM ET
$77.01
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

LeMaitre Vascular Company Profile

Company profile explained

Company Profile

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Key Executives

Name Position
George W. LeMaitre Chairman & Chief Executive Officer
Dorian LeBlanc Chief Financial Officer
Laurie A. Churchill Chief Legal Officer
Daniel J. Mumford Senior Director of Human Resources
David Roberts President & Director
George D. LeMaitre FACS Founder and Chairman of Scientific Advisory Board
Jonathan W. Ngau Senior Vice President of Information Technology
Kimberly L. Cieslak Vice President of Marketing
Maik D. Helmers Senior Vice President of Sales – Central Europe
Trent G. Kamke Senior Vice President of Operations

Latest SEC Filings

Date Type Title
Oct 15, 2026 8-K Current Report
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
View All SEC Filings ➞
LeMaitre Vascular
LeMaitre Vascular logo
Country United States
IPO Date Oct 19, 2006
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 651
CEO George W. LeMaitre

Contact Details

63 Second Avenue Burlington, Massachusetts 01803 United States

Stock Details

Ticker Symbol LMAT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001158895
CUSIP Number 525558201
ISIN Number US5255582018
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.